Mackaness James H

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$23,344.57
Insider Sells Quantity
42
Insider Sells Sum
$4.87M

Insider Activity of Mackaness James H

According to the SEC Form 4 filings, Mackaness James H, being in a position of

  1. CHIEF FINANCIAL OFFICER at Soleno Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 93705 shares for $3.76M,
    over all time since 2020-06-26, has bought 57295 shares for $19,980, and sold 93705 shares for $3.76M.

The largest purchase of all time was on 2020-06-26 and amounted to 6060 shares of Soleno Therapeutics, Inc. for $9,999.

The largest sale of all time was on 2023-12-11 and amounted to 32482 shares of Soleno Therapeutics, Inc. for $1.18M.

Biography of Mackaness James H

No biography is available at this moment.

2024-10-01SaleSoleno Therapeutics, Inc.
SLNO
CHIEF FINANCIAL OFFICER
8,077
0.0211%
$49.43$399,241+8.52%
2024-08-29SaleSoleno Therapeutics, Inc.
SLNO
CHIEF FINANCIAL OFFICER
6,870
0.0179%
$47.28$324,845+10.82%
2024-08-28SaleSoleno Therapeutics, Inc.
SLNO
CHIEF FINANCIAL OFFICER
6,661
0.0173%
$47.58$316,938+9.2%
2024-08-06SaleSoleno Therapeutics, Inc.
SLNO
CHIEF FINANCIAL OFFICER
8,134
0.0217%
$45.46$369,736+7.44%
2024-08-05SaleSoleno Therapeutics, Inc.
SLNO
CHIEF FINANCIAL OFFICER
6,849
0.019%
$45.77$313,466+10.22%
2024-07-01SaleSoleno Therapeutics, Inc.
SLNO
CHIEF FINANCIAL OFFICER
7,190
0.0207%
$41.54$298,6540%
2024-04-01SaleSoleno Therapeutics, Inc.
SLNO
CHIEF FINANCIAL OFFICER
5,175
0.0159%
$41.34$213,937+11.86%
2023-12-11SaleSoleno Therapeutics, Inc.
SLNO
Chief Financial Officer
32,482
0.1104%
$36.41$1.18M+30.33%
2023-11-30SaleSoleno Therapeutics, Inc.
SLNO
Chief Financial Officer
4,186
0.0133%
$28.65$119,937+54.18%
2023-11-29SaleSoleno Therapeutics, Inc.
SLNO
Chief Financial Officer
4,203
0.0135%
$27.83$116,986+60.15%
2023-11-28SaleSoleno Therapeutics, Inc.
SLNO
Chief Financial Officer
3,878
0.0126%
$27.12$105,190+65.73%
2022-03-31PurchaseSoleno Therapeutics, Inc.
SLNO
Chief Financial Officer
40,000
$0$0-32.29%
2021-09-13PurchaseSoleno Therapeutics, Inc.
SLNO
Chief Financial Officer
11,235
0.0139%
$0.89$9,981-66.24%
2020-06-26PurchaseSoleno Therapeutics, Inc.
SLNO
Chief Financial Officer
6,060
0.0118%
$1.65$9,999+3.26%
2015-08-19SaleIRIDEX Corporation
IRIX
CFO and COO
2,373
0.0145%
$7.15$16,967+34.98%
2015-08-18SaleIRIDEX Corporation
IRIX
CFO and COO
2,627
0.0165%
$7.10$18,658+39.01%
2015-08-17SaleIRIDEX Corporation
IRIX
CFO and COO
2,235
0.0139%
$7.05$15,757+37.69%
2015-08-14SaleIRIDEX Corporation
IRIX
CFO and COO
2,765
0.0176%
$7.05$19,493+40.9%
2015-08-13SaleIRIDEX Corporation
IRIX
CFO and COO
5,000
0.0313%
$6.95$34,750+40.33%
2015-05-20SaleIRIDEX Corporation
IRIX
CFO and COO
2,000
0.0127%
$9.80$19,609-6.31%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.